Clorox director receives deferred stock units

Clorox director Matthew J. Shattock reported two non-cash awards of Deferred Stock Units.

Rhea-AI Filing Summary

Clorox director Matthew J. Shattock reported two non-cash awards of Deferred Stock Units. He acquired 550.0838 units on June 30, 2026 and 270.7961 units on May 8, 2026, tied to dividend reinvestment and electing fees in stock under the Independent Directors' Deferred Compensation Plan. These units, which track Clorox common stock 1-for-1, will be settled in Clorox shares when he retires or otherwise leaves the board. Following the most recent award, he directly holds 20,947.1472 Deferred Stock Units.

Insider Trade Summary

Grant/Award: 820.8799 shares

Grant/Award 2 txns

Insider Shattock Matthew J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	550.0838	$0.00	$0.00
Grant/Award	Deferred Stock Units	270.7961	$0.00	$0.00

Holdings After Transaction: Deferred Stock Units — 20,947.1472 contracts (Direct)

Footnotes (4)

1. F1. 1-for-1
2. F2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
3. F3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
4. F4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

Key Figures

Deferred Stock Units granted: 550.0838 units Deferred Stock Units granted: 270.7961 units Deferred Stock Units held after latest award: 20,947.1472 units +1 more

4 metrics

Deferred Stock Units granted 550.0838 units Grant/award acquisition on June 30, 2026

Deferred Stock Units granted 270.7961 units Grant/award acquisition on May 8, 2026

Deferred Stock Units held after latest award 20,947.1472 units Total direct holdings after June 30, 2026 transaction

Price per Deferred Stock Unit $0.0000 Both June 30, 2026 and May 8, 2026 awards

Key Terms

Deferred Stock Units, Independent Directors' Deferred Compensation Plan, dividend reinvestment, quarterly director's fees

4 terms

Deferred Stock Units financial

"Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Independent Directors' Deferred Compensation Plan financial

"Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan."

A deferred compensation plan for independent directors lets outside board members postpone receiving part of their fees or stock awards until a later date, often when they retire or leave the board. Think of it as choosing to put pay into a company-run savings plan that grows and pays out later; it matters to investors because it affects director incentives, future cash or share obligations, and how aligned independent directors are with long-term company performance.

dividend reinvestment financial

"Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan."

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

quarterly director's fees financial

"Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Clorox (CLX) director Matthew Shattock report?

Matthew J. Shattock reported acquiring Deferred Stock Units in two compensation-related transactions. He received 550.0838 units on June 30, 2026 and 270.7961 units on May 8, 2026, reflecting director fees and dividend reinvestment rather than open-market buying.

Are the recent CLX insider transactions open-market stock purchases or sales?

They are not open-market trades. The Form 4 shows grant or award acquisitions of Deferred Stock Units with a zero dollar price per unit, issued under the Independent Directors' Deferred Compensation Plan, rather than discretionary buying or selling of Clorox common stock.

How many Deferred Stock Units does the CLX director hold after these awards?

After the June 30, 2026 award, Matthew J. Shattock directly holds 20,947.1472 Deferred Stock Units. Each unit is linked 1-for-1 to Clorox common stock and represents a deferred form of equity compensation, settled later instead of immediate cash payments.

What is the nature of the Deferred Stock Units reported for Clorox (CLX)?

The Deferred Stock Units are compensation instruments credited 1-for-1 to Clorox common stock. They arise from dividend reinvestment and electing to receive quarterly director fees in units, and will be settled entirely in Clorox shares upon the director’s retirement or other board service termination.

When will the reported Clorox (CLX) Deferred Stock Units be converted into shares?

The filing states the Deferred Stock Units will be settled 100% in Clorox stock in connection with Matthew J. Shattock’s retirement or other termination of service as a director. Until then, the units remain as deferred equity-based compensation rather than current common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shattock Matthew J

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CALIFORNIA 94612-1888

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	05/08/2026		A(2)	V	270.7961		(3)	(3)	Common Stock	270.7961	$0.0000	20,397.0634	D
Deferred Stock Units	(1)	06/30/2026		A(4)		550.0838		(3)	(3)	Common Stock	550.0838	$0.0000	20,947.1472	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)